Kwon Yong Tak

5PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 04, 2026
Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma.

|Feb 27, 2026
Shelterin Component TPP1 Drives Tumor Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma.

Jung Eun Jang, Hye Seon Kim, Jin Seoub Kim

|Dec 30, 2025
Prognostic Significance of Glypican-3 Expression in Hepatocellular Carcinoma Treated with Atezolizumab-Bevacizumab.

Ji Hoon Kim, Ji Won Han, Hee Sun Cho

|May 05, 2025
Quasi-spatial single-cell transcriptome based on physical tissue properties defines early aging associated niche in liver.

Kwon Yong Tak, Juyeon Kim, Myungsun Park

|May 25, 2021
Use of M2BPGi in HCC patients with TACE.

Kwon Yong Tak, Bohyun Jang, Soon Kyu Lee

Pageof 1

Frequent Collaborators

4 joint publications

Pil Soo Sung

3 joint publications

Jeong Won Jang

3 joint publications

Ji Won Han

1 joint publications

Narae Park